Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828223) titled 'Cardiac Improvement by Eplerenone Among Patients Under Cyclosporine or Tacrolimus for Kidney Transplantation' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Central Hospital, Nancy, France
Condition:
Kidney Transplantation
Intervention:
Drug: Eplerenone
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: February 2027
Target Sample Size: 132
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT07828...